CTIM-18. DENDRITIC CELL VACCINATION IN CONJUNCTION WITH ADJUVANT TLR-3 AGONIST ADMINISTRATION ENHANCES PRO-INFLAMMATORY IMMUNE RESPONSES AND IS ASSOCIATED WITH EXTENDED SURVIVAL IN MALIGNANT GLIOMA PATIENTS

Despite recent advances with immunotherapy in other tumor types, malignant glioma patients have not shown a therapeutic benefit, potentially due to the insufficient activation of an immune response. We and others have documented immune responses and extended survival following dendritic cell (DC) va...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Chavez, Carolina, Everson, Richard, Orpilla, Joey, Lee, Alexander, Khattab, Sara, Antonios, Joseph, Salazar, Andres, Cloughesy, Timothy, Liau, Linda, Sun, Lu, Hugo, Willy, Prins, Robert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Clinical Trials: Immunologic
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650313/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.152
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller